XML 33 R22.htm IDEA: XBRL DOCUMENT v3.24.2
Stockholders’ Equity (Tables)
3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Schedule of Equity Compensation Plan Information

Equity Compensation Plan Information as of March 31, 2024:

 

   Number of securities
to be issued upon exercise of outstanding options, warrants and
rights (a)
   Weighted – average exercise price of outstanding options,
warrants and rights (b)
   Number of securities remaining available for future issuances under equity
compensation plans (excluding securities reflected in column (a) (c)
 
Equity Compensation Plans Approved by Security Holders   3,275,000   $0.0401    21,680,882 
Equity Compensation Plans Not Approved by Security Holders   64,164,637    0.0293     
Total   67,439,637   $0.0299    21,680,882 
Schedule of Valuation Assumptions of Options

The Company uses the Black-Scholes option-pricing model to estimate the fair value of its stock option awards and warrant issuances. The calculation of the fair value of the awards using the Black-Scholes option-pricing model is affected by the Company’s stock price on the date of grant as well as assumptions regarding the following:

 

   Three Months ended March 31, 
   2024   2023 
Expected volatility   172.0% - 346.4%   172.0346.4%
Expected term   1.55.0 Years    1.55.0 Years 
Risk-free interest rate   0.16% - 4.64%   0.16% - 4.64%
Forfeiture rate   0.17%   0.17%
Schedule of Outstanding Stock Option Activity

A summary of the status of the Company’s outstanding stock options as of March 31, 2024 and December 31, 2023 and changes during the periods ending on such dates is as follows:

 

   Number of  

Weighted

Average

Exercise

  

Weighted

Average

Remaining

Contractual

  

Aggregate

Intrinsic

 
   Options   Price   Life in Years   Value 
Outstanding at December 31, 2022   238,439,167   $0.0362    1.43               
Granted   -    -           
Forfeited   (170,999,530)   0.0379           
Exercised   -    -           
Cancelled   -    -           
Outstanding – December 31, 2023   67,439,637   $0.0360    1.43      
Exercisable – December 31, 2023   41,057,753   $0.0211    0.81   $- 
                     
Granted   -    -           
Forfeited   -    -           
Exercised   -    -           
Cancelled   -    -           
Outstanding – March 31, 2024   67,439,637   $0.0298    1.26      
Exercisable – March 31, 2024   42,323,387   $0.0217    0.61   $- 
Summary of Exercise Price of Employee Stock Options Outstanding

The following table summarizes information about employee stock options outstanding at March 31, 2024.

 

Range of Exercise Price  Number
outstanding
at March 31,
2024
   Weighted
average
remaining
Life
   Weighted
average
exercise
price
   Number
exercisable
at March 31,2024
   Weighted
average
exercise
price
   Weighted
average
remaining
life
 
$ 0.0180 - $0.0225   35,295,237    0.33   $0.0180    35,295,237   $0.0180    0.33 
$ 0.0229 - $0.0325   1,050,000    2.14   $0.0324    1,043,750   $0.0324    2.14 
$ 0.0360 - $0.0425   23,009,400    2.29   $0.0398    5,009,400   $0.0393    2.11 
$ 0.0440 - $0.0531   8,085,000    2.31   $0.0529    975,000   $0.0517    1.46 
Outstanding options   67,439,637    1.26    0.0298    42,323,387    0.0217    0.61 

Schedule of Warrants Activity

A summary of the Company’s warrants as of December 31, 2023 and changes during the three months ended March 31, 2024 is presented below:

 

   Number of  

Weighted

Average

Exercise

  

Weighted

Average

Remaining

Contractual

  

Aggregate

Intrinsic

 
   Warrants   Price   Life in Years   Value 
Outstanding – December 31, 2023   25,684,521   $0.0247    0.93   $24,000 
Granted   -                
Exercised   -                
Forfeited or Expired   -                
Outstanding – March 31, 2024   25,684,521   $0.0247    0.68      
Exercisable – March 31, 2024   25,684,521   $0.0247    0.68   $-